Fetal intravenous immunoglobulin therapy in rhesus hemolytic disease
- PMID: 17143009
- DOI: 10.1159/000097661
Fetal intravenous immunoglobulin therapy in rhesus hemolytic disease
Abstract
Intrauterine blood transfusion is the mainstay of treatment of fetal rhesus hemolytic anemia with optimal perinatal outcome. Postnatal immunoglobulin therapy has been successfully used in the management of alloimmunized neonates and has shown to decrease the need for exchange transfusion. We report the first case series of fetal immunoglobulin therapy in the antenatal management of severe Rh incompatibility.
Copyright (c) 2007 S. Karger AG, Basel.
Similar articles
-
Outcome of alloimmunized fetuses managed solely by cordocentesis but not requiring antenatal transfusion.Fetal Diagn Ther. 1994 Jul-Aug;9(4):233-8. doi: 10.1159/000263939. Fetal Diagn Ther. 1994. PMID: 7945903
-
Intrauterine red cell transfusion for anti-Kell isoimmunization in a fetus with Glanzmann's thrombasthenia.Prenat Diagn. 2013 Nov;33(11):1107-9. doi: 10.1002/pd.4201. Epub 2013 Aug 21. Prenat Diagn. 2013. PMID: 23861189 No abstract available.
-
[Analysis and perinatal outcome after intravascular transfusion].Ginecol Obstet Mex. 2011 Jun;79(6):351-7. Ginecol Obstet Mex. 2011. PMID: 21966826 Spanish.
-
Intrauterine transfusion and non-invasive treatment options for hemolytic disease of the fetus and newborn - review on current management and outcome.Expert Rev Hematol. 2017 Apr;10(4):337-344. doi: 10.1080/17474086.2017.1305265. Epub 2017 Mar 20. Expert Rev Hematol. 2017. PMID: 28277805 Review.
-
Therapeutic management of fetal anemia: review of standard practice and alternative treatment options.J Perinat Med. 2013 Jan;41(1):71-82. doi: 10.1515/jpm-2012-0093. J Perinat Med. 2013. PMID: 23093258 Review.
Cited by
-
Hemolytic disease of the fetus and newborn: systematic literature review of the antenatal landscape.BMC Pregnancy Childbirth. 2023 Jan 7;23(1):12. doi: 10.1186/s12884-022-05329-z. BMC Pregnancy Childbirth. 2023. PMID: 36611144 Free PMC article.
-
Efficacy of Antenatal Intravenous Immunoglobulin Treatment in Pregnancies at High Risk due to Alloimmunization to Red Blood Cells.Transfus Med Hemother. 2018 Nov;45(6):429-436. doi: 10.1159/000490154. Epub 2018 Oct 31. Transfus Med Hemother. 2018. PMID: 30574060 Free PMC article.
-
Antenatal immunoglobulin for fetal red blood cell alloimmunization.Cochrane Database Syst Rev. 2013 May 31;2013(5):CD008267. doi: 10.1002/14651858.CD008267.pub2. Cochrane Database Syst Rev. 2013. PMID: 23728672 Free PMC article.
-
Early intravenous immunoglobin (two-dose regimen) in the management of severe Rh hemolytic disease of newborn--a prospective randomized controlled trial.Eur J Pediatr. 2011 Apr;170(4):461-7. doi: 10.1007/s00431-010-1310-8. Epub 2010 Oct 6. Eur J Pediatr. 2011. PMID: 20924607 Clinical Trial.
-
Hemolytic disease of the fetus and newborn: rapid review of postnatal care and outcomes.BMC Pregnancy Childbirth. 2023 Oct 18;23(1):738. doi: 10.1186/s12884-023-06061-y. BMC Pregnancy Childbirth. 2023. PMID: 37853331 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical